Table 1.
Subject | Gender | Age | tTG IgA1 | EMA IgA | Clinical history |
1 | M | 24 | 7.6 | +++ | a |
2 | F | 28 | 1.27 | + | t |
3 | F | 22 | 2.42 | +++ | n |
4 | F | 24 | 3.6 | ++ | n |
5 | F | 23 | 8.25 | +++ | a |
6 | F | 20 | 3.15 | ++ | n |
7 | F | 20 | 6.6 | +++ | n |
8 | F | 22 | 4.87 | +++ | a |
9 | F | 25 | 9.1 | +++ | n |
10 | F | 18 | 9.89 | + | a |
11 | F | 24 | 9.13 | +++ | n |
12 | F | 27 | 7.6 | + | n |
13 | F | 24 | 4.25 | +++ | n |
14 | F | 22 | 6.78 | ++ | a |
Using qualitative evaluation ratio for tissue transglutaminase (tTG) IgA the cutoff for the positive > 1.2, equivocal 0.85-1.2, and negative subjects < 0.85. a: Anemia; t: Thyroid disorder; n: No complain; M: Male; F: Female; EMA: Anti-endomysial antibodies.